journal article·2021

Strontium-doped gelatin scaffolds promote M2 macrophage switch and angiogenesis through modulating the polarization of neutrophils

Tao Li, Hongtao He, Zezheng Yang, Junjie Wang, Yuxin Zhang, Guangxu He, Jun Huang, Deye Song, Jiangdong Ni, Xiaojun Zhou, Junfeng Zhu, Muliang Ding

Biomaterials Science· Volume 9· Issue 8
This record is marked as retracted by the source. Review the publisher’s notice before using its findings.
Publisher page

Abstract

The immune system mediates inflammation, vascularization and the first response to injuries or implanted biomaterials. Although the function of neutrophils in tissue repair has been extensively studied, its complete role in the tissue regeneration of biomaterials, specifically the resolution of inflammation and promotion of angiogenesis, is unclear. Here, we fabricate nanofibrous gelatin scaffolds containing 10% (w/w) strontium-hydroxyapatite (SrHA) via phase-separation methods to investigate Sr-mediated regulation of neutrophil polarization and, subsequently, the effects on angiogenesis and macrophage polarization. Compared with neutrophils cultured on pure gelatin or HA-incorporated gelatin scaffolds, neutrophils on SrHA-incorporated gelatin scaffolds show more N2 polarization in vitro and in vivo and significantly greater production of immunomodulatory and angiogenic factors. The Sr-induced immunomodulatory and proangiogenic functions of neutrophils are mediated through NF-κB pathway downregulation and increased STAT3 phosphorylation. Thus, neutrophils play a vital role in tissue engineering, and Sr-incorporated scaffolds efficiently promote neutrophil polarization to the N2 phenotype, enhancing resolution of inflammation and ultimately promoting angiogenesis and tissue regeneration. Thus, incorporation of neutrophils in analyses of the immune characteristics of scaffolds and the development of immunomodulatory biomaterials that can regulate neutrophils are novel and promising strategies in tissue engineering.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Immune cells in cancer · Macrophage Migration Inhibitory Factor · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedics

The Second Xiangya Hospital

Central South University

Changsha

P.R. China

The Third Ward of Department of Orthopedics

The Second Hospital of Dalian Medical University

Dalian

P. R. China

Department of Orthopedics

The Fifth People's Hospital of Shanghai

Fudan University

Shanghai 200240

Department of Rehabilitation Medicine

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai 200011

China

College of Chemistry

Chemical Engineering and Biotechnology; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials

Donghua University

Shanghai 201620

Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine

Shanghai

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (63)

Show source-provided references
1. Griffith · Science · 2002 · 295 · 100910.1126/science.1069210 ↗
2. Li · Acta Biomater. · 2018 · 71 · 9610.1016/j.actbio.2018.03.012 ↗
3. Zhang · Theranostics · 2018 · 8 · 534810.7150/thno.27385 ↗
4. Li · ACS Appl. Mater. Interfaces · 2019 · 11 · 1713410.1021/acsami.8b22017 ↗
5. Su · Biomaterials · 2017 · 141 · 7410.1016/j.biomaterials.2017.06.028 ↗
6. Zhao · Biomaterials · 2018 · 178 · 3610.1016/j.biomaterials.2018.06.004 ↗
7. Xiao · Acta Biomater. · 2020 · 106 · 2210.1016/j.actbio.2019.12.034 ↗
8. Julier · Acta Biomater. · 2017 · 53 · 1310.1016/j.actbio.2017.01.056 ↗
9. Feng · Biomaterials · 2017 · 134 · 12810.1016/j.biomaterials.2017.04.042 ↗
10. Spiller · Biomaterials · 2014 · 35 · 447710.1016/j.biomaterials.2014.02.012 ↗
11. Guo · J. Mater. Chem. B · 2020 · 8 · 604810.1039/D0TB00282H ↗
12. Selders · Regener. Biomater. · 2017 · 4 · 5510.1093/rb/rbw041 ↗
13. Dai · Biomaterials · 2020 · 240 · 11984110.1016/j.biomaterials.2020.119841 ↗
14. Mantovani · Nat. Rev. Immunol. · 2011 · 11 · 51910.1038/nri3024 ↗
15. Piccard · Crit. Rev. Oncol. Hematol. · 2012 · 82 · 29610.1016/j.critrevonc.2011.06.004 ↗
16. Fridlender · Cancer Cell · 2009 · 16 · 18310.1016/j.ccr.2009.06.017 ↗
17. Kumar · Int. Immunopharmacol. · 2010 · 10 · 132510.1016/j.intimp.2010.08.012 ↗
18. Perobelli · Braz. J. Med. Biol. Res. · 2015 · 48 · 66510.1590/1414-431x20154524 ↗
19. Ohms · Front. Immunol. · 2020 · 11 · 53210.3389/fimmu.2020.00532 ↗
20. Sionov · Cancer Microenviron. · 2015 · 8 · 12510.1007/s12307-014-0147-5 ↗
21. Lin · Nat. Biomed. Eng. · 2017 · 1 · 008110.1038/s41551-017-0081 ↗
22. Chen · Biomaterials · 2015 · 61 · 12610.1016/j.biomaterials.2015.04.044 ↗
23. Li · Stem Cell Res. Ther. · 2018 · 9 · 10010.1186/s13287-018-0818-0 ↗
24. Zhang · ACS Appl. Mater. Interfaces · 2016 · 8 · 3074710.1021/acsami.6b10378 ↗
25. Brown · Front. Immunol. · 2014 · 5 · 510
26. Saino · Biomacromolecules · 2011 · 12 · 190010.1021/bm200248h ↗
27. Huang · ACS Biomater. Sci. Eng. · 2020 · 6 · 327010.1021/acsbiomaterials.0c00443 ↗
28. Han · Colloids Surf., B · 2019 · 179 · 36310.1016/j.colsurfb.2019.04.011 ↗
29. Rahmati · ACS Appl. Bio Mater. · 2020 · 3 · 516910.1021/acsabm.0c00608 ↗
30. Autefage · Biomaterials · 2019 · 209 · 15210.1016/j.biomaterials.2019.03.035 ↗
31. Wang · Biomater. Sci. · 2016 · 4 · 67810.1039/C5BM00482A ↗
32. Tohidnezhad · Int. J. Mol. Sci. · 2020 · 21 · 320810.3390/ijms21093208 ↗
33. Jamalpoor · Iran. J. Allergy, Asthma Immunol. · 2018 · 17 · 39810.18502/ijaai.v17i5.298 ↗
34. Sharma · Mater. Sci. Eng., C · 2016 · 64 · 41610.1016/j.msec.2016.03.060 ↗
35. Kim · J. Biomed. Mater. Res., Part B · 2005 · 75 · 44210.1002/jbm.b.30324 ↗
36. Zhang · Acta Biomater. · 2011 · 7 · 80010.1016/j.actbio.2010.08.031 ↗
37. Mauck · Ann. Biomed. Eng. · 2015 · 43 · 52910.1007/s10439-015-1249-z ↗
38. Zhao · Nat. Commun. · 2017 · 8 · 60210.1038/s41467-017-00770-7 ↗
39. Zhang · Mol. Cancer · 2018 · 17 · 14610.1186/s12943-018-0898-6 ↗
40. Loi · Bone · 2016 · 86 · 11910.1016/j.bone.2016.02.020 ↗
41. Won · Biomaterials · 2020 · 227 · 11954810.1016/j.biomaterials.2019.119548 ↗
42. Li · Nanotechnology · 2018 · 29 · 08400110.1088/1361-6528/aaa2b4 ↗
43. Lu · Med. Sci. Monit. · 2019 · 25 · 265810.12659/MSM.914269 ↗
44. Wang · Mater. Sci. Eng., C · 2019 · 103 · 10983310.1016/j.msec.2019.109833 ↗
45. Lee · J. Leukocyte Biol. · 1993 · 54 · 28310.1002/jlb.54.4.283 ↗
46. Nakazawa · J. Autoimmun. · 2016 · 67 · 1910.1016/j.jaut.2015.08.018 ↗
47. Lu · Med. Sci. Monit. · 2019 · 25 · 265810.12659/MSM.914269 ↗
48. Zhao · Biomaterials · 2018 · 178 · 3610.1016/j.biomaterials.2018.06.004 ↗
49. Yuan · Front. Immunol. · 2017 · 8 · 119610.3389/fimmu.2017.01196 ↗
50. Kargozar · Acta Biomater. · 2017 · 58 · 50210.1016/j.actbio.2017.06.021 ↗
51. Wei · ACS Appl. Mater. Interfaces · 2019 · 11 · 3059610.1021/acsami.9b10219 ↗
52. Tazzyman · Int. J. Exp. Pathol. · 2009 · 90 · 22210.1111/j.1365-2613.2009.00641.x ↗
53. Tazzyman · Semin. Cancer Biol. · 2013 · 23 · 14910.1016/j.semcancer.2013.02.003 ↗
54. Ardi · Proc. Natl. Acad. Sci. U. S. A. · 2007 · 104 · 2026210.1073/pnas.0706438104 ↗
55. Chiang · Oncotarget · 2017 · 8 · 2070610.18632/oncotarget.14982 ↗
56. Luo · Aging · 2017 · 9 · 206910.18632/aging.101302 ↗
57. Tong · Sci. Rep. · 2018 · 8 · 324110.1038/s41598-018-21674-6 ↗
58. Zou · Oncotarget · 2017 · 8 · 3350110.18632/oncotarget.16819 ↗
59. Lokuta · J. Leukocyte Biol. · 2005 · 78 · 21010.1189/jlb.0205067 ↗
60. Zhang · Acta Biomater. · 2011 · 7 · 80010.1016/j.actbio.2010.08.031 ↗
61. Lourenço · Mater. Sci. Eng., C · 2019 · 99 · 128910.1016/j.msec.2019.02.053 ↗
62. Deng · Sci. Rep. · 2017 · 7 · 558810.1038/s41598-017-05196-1 ↗
63. Yan · J. Immunol. · 2013 · 190 · 588210.4049/jimmunol.1201881 ↗